{"transactions":[{"id":1765242,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-04T21:28:38.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":137725,"price":1.35,"value":185928.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Closing (as defined in the Agreement and Plan of Merger and Reorganization dated June 29, 2023 (the \"Merger Agreement\"), by an among the Issuer, Ibiza Merger Sub, Inc., and Morphimmune Inc.), Dr. Prendergast exchanged (i) his shares of common stock of Morphimmune for shares of the Issuer and (ii) his options to acquire shares of common stock of Morphimmune for options to acquire shares of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the Closing (as defined in the Merger Agreement), all the shares underlying the option became fully vested and exercisable."}],"balance_after":137725,"derivative":{"exercise_price":1.35,"expiration_date":"2032-09-26","underlying":"Common Stock","underlying_shares":137725},"source":{"system":"sec-edgar","filing":"0001209191-23-052048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919123052048/doc4.xml","form_type":"4"}},{"id":1765241,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T21:28:38.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":60840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the Closing (as defined in the Agreement and Plan of Merger and Reorganization dated June 29, 2023 (the \"Merger Agreement\"), by an among the Issuer, Ibiza Merger Sub, Inc., and Morphimmune Inc.), Dr. Prendergast exchanged (i) his shares of common stock of Morphimmune for shares of the Issuer and (ii) his options to acquire shares of common stock of Morphimmune for options to acquire shares of the Issuer."}],"balance_after":60840,"source":{"system":"sec-edgar","filing":"0001209191-23-052048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000120919123052048/doc4.xml","form_type":"4"}},{"id":1858690,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T20:51:18.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":4.84,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-23-070397","document":"tm2318426-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465923070397/tm2318426-4_4seq1.xml","form_type":"4"}},{"id":2161431,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-09-12T17:01:33.000Z","date":"2022-09-09","kind":"grant","acquired":true,"shares":37600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares shall vest on the first anniversary of September 9, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months."}],"balance_after":37600,"derivative":{"exercise_price":0.6,"expiration_date":"2032-09-09","underlying":"Common Stock","underlying_shares":37600},"source":{"system":"sec-edgar","filing":"0001104659-22-099288","document":"tm2225655-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000110465922099288/tm2225655-4_4seq1.xml","form_type":"4"}},{"id":2225335,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T22:03:42.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the options shall vest 25% every quarter after the grant date."}],"balance_after":6500,"derivative":{"exercise_price":2.62,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":6500},"source":{"system":"sec-edgar","filing":"0001104659-22-073096","document":"tm2218674-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465922073096/tm2218674-4_4seq1.xml","form_type":"4"}},{"id":2521511,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-08T21:05:48.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":3200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 36-month period commencing upon December 4, 2021."}],"balance_after":3200,"derivative":{"exercise_price":10.32,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":3200},"source":{"system":"sec-edgar","filing":"0001213900-21-057327","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763950/000121390021057327/ownership.xml","form_type":"4"}},{"id":2566339,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-09-17T16:17:13.000Z","date":"2021-08-19","kind":"grant","acquired":true,"shares":38135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares shall vest on the first anniversary of August 19, 2021, and the remaining shares shall vest on an equal monthly basis over the following 36 months."}],"balance_after":38135,"derivative":{"exercise_price":3.36,"expiration_date":"2031-08-19","underlying":"Common Stock","underlying_shares":38135},"source":{"system":"sec-edgar","filing":"0001104659-21-116924","document":"tm2127926-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000110465921116924/tm2127926-2_4seq1.xml","form_type":"4"}},{"id":2660873,"issuer":{"id":4219,"kind":"organization","name":"Immunome Inc.","symbol":"IMNM"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T00:07:12.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest one-twelfth (1/12th) every quarter after the grant date."}],"balance_after":7500,"derivative":{"exercise_price":16.96,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-21-083670","document":"tm2118079-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1472012/000110465921083670/tm2118079-12_4seq1.xml","form_type":"4"}},{"id":3033382,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-09-11T17:19:49.000Z","date":"2020-09-09","kind":"grant","acquired":true,"shares":14634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total shares shall vest on the first anniversary of September 9, 2020, and the remaining shares shall vest on an equal monthly basis over the following 36 months."}],"balance_after":14634,"derivative":{"exercise_price":8.8,"expiration_date":"2030-09-09","underlying":"Common Stock","underlying_shares":14634},"source":{"system":"sec-edgar","filing":"0001104659-20-104488","document":"tm2030658d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000110465920104488/tm2030658d1_4.xml","form_type":"4"}},{"id":3110721,"issuer":{"id":7525,"kind":"organization","name":"Lantern Pharma Inc."},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-06-15T21:33:45.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":9135,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's initial public offering (\"IPO\"). The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's initial public offering (\"IPO\"). The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's initial public offering (\"IPO\"). The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's initial public offering (\"IPO\"). The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date."}],"balance_after":9135,"derivative":{"exercise_price":15,"underlying":"Common Stock","underlying_shares":9135},"source":{"system":"sec-edgar","filing":"0001213900-20-015049","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1763950/000121390020015049/ownership.xml","form_type":"4"}},{"id":3431895,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-08-21T17:29:03.000Z","date":"2019-07-23","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest monthly in twelve equal installments beginning on August 23, 2019."}],"balance_after":100000,"derivative":{"exercise_price":0.15,"exercise_date":"2019-08-23","expiration_date":"2029-07-23","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000905718-19-000723","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000090571819000723/ownership.xml","form_type":"4"}},{"id":3460977,"issuer":{"id":109568,"kind":"organization","name":"NeuBase Therapeutics, Inc.","symbol":"NBSE"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-07-16T20:36:42.000Z","date":"2019-07-12","kind":"grant","acquired":true,"shares":227330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the total shares subject to the option shall vest monthly over three years."}],"balance_after":227330,"derivative":{"exercise_price":5.39,"expiration_date":"2029-07-12","underlying":"Common stock","underlying_shares":227330},"source":{"system":"sec-edgar","filing":"0001387131-19-005133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1173281/000138713119005133/ownership.xml","form_type":"4"}},{"id":135120,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-22T15:02:50.000Z","date":"2017-11-20","kind":"grant","acquired":true,"shares":802,"price":83.18,"value":66710.36,"ownership":{"direct":true},"balance_after":68574,"source":{"system":"sec-edgar","filing":"0000059478-17-000217","document":"wf-form4_151136295636158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947817000217/wf-form4_151136295636158.xml","form_type":"4"}},{"id":4197512,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-02T17:09:26.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on September 28, 2018 and September 28, 2019, respectively."}],"balance_after":5000,"derivative":{"exercise_price":2.75,"exercise_date":"2018-09-28","expiration_date":"2027-09-28","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001349929-17-000083","document":"wf-form4_150697855216217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000134992917000083/wf-form4_150697855216217.xml","form_type":"4"}},{"id":4197511,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-10-02T17:09:26.000Z","date":"2017-09-28","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on September 28, 2018 and September 28, 2019, respectively."}],"balance_after":12500,"source":{"system":"sec-edgar","filing":"0001349929-17-000083","document":"wf-form4_150697855216217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000134992917000083/wf-form4_150697855216217.xml","form_type":"4"}},{"id":4288181,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-08T16:30:44.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on June 7, 2018 and June 7, 2019, respectively."}],"balance_after":10000,"derivative":{"exercise_price":4.15,"exercise_date":"2018-06-07","expiration_date":"2027-06-07","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349929-17-000043","document":"wf-form4_149695382379067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000134992917000043/wf-form4_149695382379067.xml","form_type":"4"}},{"id":4288180,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2017-06-08T16:30:44.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on June 7, 2018 and June 7, 2019, respectively."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001349929-17-000043","document":"wf-form4_149695382379067.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000134992917000043/wf-form4_149695382379067.xml","form_type":"4"}},{"id":146169,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-01T22:21:53.000Z","date":"2016-11-30","kind":"grant","acquired":true,"shares":2088,"price":76.64,"value":160024.32,"ownership":{"direct":true},"balance_after":66904,"source":{"system":"sec-edgar","filing":"0000059478-16-000471","document":"wf-form4_148063089946491.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000471/wf-form4_148063089946491.xml","form_type":"4"}},{"id":4580027,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-10-13T16:32:26.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments on October 11, 2017 and October 11, 2018, respectively."}],"balance_after":10000,"derivative":{"exercise_price":1.81,"exercise_date":"2017-10-11","expiration_date":"2026-10-11","underlying":"Common Stock, par value $0.0001 per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001349929-16-000120","document":"wf-form4_147639073362969.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000134992916000120/wf-form4_147639073362969.xml","form_type":"4"}},{"id":4580026,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2016-10-13T16:32:26.000Z","date":"2016-10-11","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock underlying the award vests in two equal installments on October 11, 2017 and October 11, 2018, respectively."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001349929-16-000120","document":"wf-form4_147639073362969.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1233256/000134992916000120/wf-form4_147639073362969.xml","form_type":"4"}},{"id":158702,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2015-12-02T20:30:45.000Z","date":"2015-11-30","kind":"grant","acquired":true,"shares":1785,"price":81.23,"value":144995.55,"ownership":{"direct":true},"balance_after":63139,"source":{"system":"sec-edgar","filing":"0000059478-15-000217","document":"wf-form4_144908823239151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947815000217/wf-form4_144908823239151.xml","form_type":"4"}},{"id":168562,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2014-12-02T21:03:40.000Z","date":"2014-11-28","kind":"grant","acquired":true,"shares":2155,"price":67.29,"value":145009.95,"ownership":{"direct":true},"balance_after":59810,"source":{"system":"sec-edgar","filing":"0000059478-14-000212","document":"wf-form4_141755420857171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947814000212/wf-form4_141755420857171.xml","form_type":"4"}},{"id":178637,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2013-12-03T20:32:58.000Z","date":"2013-11-29","kind":"grant","acquired":true,"shares":2841,"price":51.03,"value":144976.23,"ownership":{"direct":true},"balance_after":55757,"source":{"system":"sec-edgar","filing":"0000059478-13-000103","document":"wf-form4_138610276737052.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947813000103/wf-form4_138610276737052.xml","form_type":"4"}},{"id":189399,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2012-12-03T19:42:45.000Z","date":"2012-11-30","kind":"grant","acquired":true,"shares":3083,"price":47.03,"value":144993.49,"ownership":{"direct":true},"balance_after":51003,"source":{"system":"sec-edgar","filing":"0001209191-12-055294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919112055294/doc4.xml","form_type":"4"}},{"id":197789,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2011-12-01T18:52:35.000Z","date":"2011-11-30","kind":"grant","acquired":true,"shares":3990,"price":36.34,"value":144996.6,"ownership":{"direct":true},"balance_after":45812,"source":{"system":"sec-edgar","filing":"0001209191-11-058686","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919111058686/doc4.xml","form_type":"4"}},{"id":209357,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2010-12-01T15:15:43.000Z","date":"2010-11-30","kind":"grant","acquired":true,"shares":4187,"price":34.63,"value":144995.81,"ownership":{"direct":true},"balance_after":39682,"source":{"system":"sec-edgar","filing":"0001209191-10-057442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919110057442/doc4.xml","form_type":"4"}},{"id":218825,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2009-12-01T21:24:28.000Z","date":"2009-11-30","kind":"grant","acquired":true,"shares":4040,"price":35.89,"value":144995.6,"ownership":{"direct":true},"balance_after":33670,"source":{"system":"sec-edgar","filing":"0001209191-09-054816","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919109054816/doc4.xml","form_type":"4"}},{"id":227998,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2008-12-02T19:58:43.000Z","date":"2008-11-28","kind":"grant","acquired":true,"shares":4513,"price":32.13,"value":145002.69,"ownership":{"direct":true},"balance_after":28005,"source":{"system":"sec-edgar","filing":"0001209191-08-063522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919108063522/doc4.xml","form_type":"4"}},{"id":241110,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2007-12-03T21:09:30.000Z","date":"2007-11-30","kind":"grant","acquired":true,"shares":2840,"price":51.055,"value":144996.2,"ownership":{"direct":true},"balance_after":22623,"source":{"system":"sec-edgar","filing":"0001209191-07-067244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919107067244/doc4.xml","form_type":"4"}},{"id":254048,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2006-12-04T18:43:43.000Z","date":"2006-11-30","kind":"grant","acquired":true,"shares":2672,"price":54.26,"value":144982.72,"ownership":{"direct":true},"balance_after":19190,"source":{"system":"sec-edgar","filing":"0001209191-06-062603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919106062603/doc4.xml","form_type":"4"}},{"id":270526,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2005-12-01T21:32:48.000Z","date":"2005-11-30","kind":"grant","acquired":true,"shares":1500,"price":50.505,"value":75757.5,"ownership":{"direct":true},"balance_after":16061,"source":{"system":"sec-edgar","filing":"0001209191-05-060457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000120919105060457/doc4.xml","form_type":"4"}},{"id":284285,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2004-12-02T16:09:36.000Z","date":"2004-11-30","kind":"grant","acquired":true,"shares":700,"price":56.59,"value":39613.0,"ownership":{"direct":true},"balance_after":14173.11,"source":{"system":"sec-edgar","filing":"0000059478-04-000189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000189/doc4.xml","form_type":"4"}},{"id":295091,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2004-02-19T20:09:12.000Z","date":"2004-02-17","kind":"grant","acquired":true,"shares":2800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2800,"derivative":{"exercise_price":73.11,"exercise_date":"2007-02-19","expiration_date":"2014-02-14","underlying":"Common Stock","underlying_shares":2800},"source":{"system":"sec-edgar","filing":"0000059478-04-000077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947804000077/doc4.xml","form_type":"4"}},{"id":297904,"issuer":{"id":2794,"kind":"organization","name":"ELI LILLY & Co","symbol":"LLY"},"owners":[{"id":12236,"kind":"person","name":"PRENDERGAST FRANKLYN G","position":1,"cik":"0001233256","reported_name":"PRENDERGAST FRANKLYN G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2003-12-01T19:04:52.000Z","date":"2003-11-26","kind":"grant","acquired":true,"shares":700,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13208.11,"source":{"system":"sec-edgar","filing":"0000059478-03-000044","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947803000044/doc4.xml","form_type":"4"}}]}